Endometrial cancer (EC) is one of the most common gynaecological malignancies in high-income countries and is associated with ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

With improving cancer survival rates, fertility preservation has become essential for reproductive-age women facing ...

The U.S. Food and Drug Administration on April 21, 2026, approved Merck’s Idvynso, a once-daily combination pill for HIV ...

Objectives Depict football players’ average times to return to sports (RTS) after non-contact lower limb soft-tissue injuries ...

The VESALIUS-CV trial, published in JAMA and presented at ACC 2026 as a late-breaking abstract, marks a significant expansion ...

For adults with chronic low back pain (cLBP), physical therapy (PT) may be beneficial as first-line therapy, according to a ...

Orforglipron significantly reduces body weight across all BMI categories in the ATTAIN-1 trial, with results presented at AACE 2026.

Researchers report encouraging long-term results from an experimental treatment approach that rethinks the timing of cancer ...

OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced new clinical data demonstrating a significant association between femoral subchondral bone shape, measured by B-score, ...

Voice-based AI tools claim to help predict loan defaults from speech acoustics alone. Some regulators say the burden of proof ...

This is not the first occasion on which I have taken legal action against the government. I now bring a further Judicial Review challenge in respect of recent policy changes affecting the Motability ...